US 11053262
Heterocyclic amide compounds having RORyT inhibitory action
granted A61PA61P1/04A61P17/06
Quick answer
US patent 11053262 (Heterocyclic amide compounds having RORyT inhibitory action) held by Takeda Pharmaceutical Company Limited expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/02, A61P25/00